Conferences/Symposiums of NF2 interest, worldwide http://www.advocurenf2.org/01_symposiums.html http://blogs.law.harvard.edu/tech/rss 25 Aug 2010 14:00:00 -0400 2011 NF Conference, June 11-14, 2011 in Jackson Hole, WY, USA. Hosted by the Children's Tumor Foundation (CTF). 11 Jun 2011 12:00:00 -0400 http://www.ctf.org/For-Scientists/2010-NF-Conference/ NF Symposium, October 24, 2010 in Boston MA, USA. Sponsored by the Center for Neurofibromatosis and Allied Disorders (CNfAD). 24 Oct 2010 12:00:00 -0400 http://www.cnfad.org/Save_the_Date.pdf NF Symposium, October 16, 2010 in Chicago IL, USA. Hosted by Neurofibromatosis Midwest - NF Inc. 16 Oct 2010 12:00:00 -0400 http://www.nfmidwest.org/symposium2010.html 14th European NF-Meeting, September 9-12, 2010 in Oslo, Norway. 09 Sep 2010 12:00:00 -0500 http://www.ctf.org/For-Scientists/2009-NF-Conference/ 2010 NF Conference: Back to the Future, June 5-10, 2010 in Baltimore, MD, USA. Hosted by the Children's Tumor Foundation (CTF). 05 Jun 2010 12:00:00 -0400 http://www.ctf.org/For-Scientists/2009-NF-Conference/ NF2 Meeting: The State of the Art, May 2-4, 2010 in Las Vegas, NV, USA. Sponsored by the House Ear Institute (HEI). Despite the fact that significant progress has been made in the understanding of the biology of neurofibromatosis type 2 (NF2), patients with this disorder still face a poor clinical outcomes, significant morbidity and a decreased life span. The NF2 field is at a critical juncture and the goal of this conference is to provide a regular forum to bring together biologists, geneticists, clinicians, neurosurgeons, audiologists and others familiar with NF2 to share their latest basic and clinical research findings and experiences, with the ultimate goal to undertake international translational research projects and initiate NF2-specific targeted therapeutic trials. Relevant questions to be discussed in this meeting are: 1. What Do We Know - and Don’t Know - About NF2 Biology? 2. What is the natural history of NF2 tumors and its impact on clinical management? 3. Radiosurgery and Radiotherapy for NF2 Tumors? 4. What is the Satus of auditory rehabilitation in NF2 patients? 5. What is the Status of NF2 Preclinical Screening Tools? 6. What are Critical Endpoints in Evaluating NF2 Therapeutic Efficacy and Outcome? 7. What Are the Candidate Drugs and Potential Therapeutic Approaches for NF2? In addition, there will be a special function honoring the career and contributions of Dr. William Hitselberger to acoustic neuroma and auditory brainstem implant surgical techniques. 02 May 2010 12:00:00 -0400 http://www.ctf.org/For-Scientists/NF2-Meeting/ 2009 NF Conference: New Frontiers, June 13-16, 2009 in Portland, OR, USA. Hosted by the Children's Tumor Foundation (CTF). What’s New in Neurofibromatosis? Proceedings From The 2009 NF Conference: New Frontiers - full review. 13 Jun 2009 12:00:00 -0400 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818482/ Strategic Planning for NF2 Clinical Trials, Oct 5-7, 2007 in Manhattan, NY, USA. Hosted by the Children's Tumor Foundation (CTF), and attended by Advocure NF2 Inc. This meeting was a strategic planning workshop to discuss and resolve the barriers that have to date limited progress in NF2 clinical trials. These issues include recruitment, protocols, endpoints, and candidate drug/targets. Top researchers and scientists from the NF2 field as well as laypersons from the NF2 community convened at this 2-day workshop. Published August 2009 in: Clin Canccer Res, titled: "Consensus Recommendations to Accelerate Clinical Trials for Neurofibromatosis type 2." 05 Oct 2007 12:00:00 -0400 http://www.ncbi.nlm.nih.gov/pubmed/19671848?ordinalpos=1&itool=Email.EmailReport.Pubmed_ReportSelector.Pubmed_RVDocSum